Advertisement

Topics

Beta Technology Ltd Company Profile

18:22 EDT 24th June 2018 | BioPortfolio

Beta Technology Ltd is a private company established in 1984, by Dr Bob Keown OBE.

Originally a lecturer in Metallurgy at Sheffield University, Bob set up his own consultancy company in 1984 and later went on to set up an employment agency hiring out scientists to industry such as British Steel (Corus), the National Physical Laboratory (NPL) and the Central Science Laboratory (CSL).

Since then the company has grown in size and taken on more public sector contracts from organisations such as the DTI, DEFRA (formally known as MAFF), Yorkshire Forward, European Commission (EC), Advantage West Midlands and One NorthEast.

Today Beta's main objective is to encourage small and large companies throughout the UK to be more technically proactive.

Beta does this by providing assistance to companies wanting to apply for European research and development funding and by providing innovation services to companies to help them develop, promote and acquire new technologies.

Beta is the designated UK National Contact Point (NCP) for a number of areas of FP6 including SMEs, Life Sciences and Research and Innovation. Additionally, Beta is the Innovation Relay Centre (IRC) for the Yorkshire and Humber region and is a partner in 5 FP6 projects.

Beta's head office is located in Doncaster, South Yorkshire and we have a subsidiary office in Middlesbrough on Teesside. The Company currently employs 28 full time staff and 40 consultants and researchers.

Location

Barclay CourtDoncaster Carr
Doncaster
South Yorkshire
DN4 5HZ
United Kingdom

Contact

Phone: 44 (0) 1302 322633
Fax: 44 (0) 1302 388800
Email: info@betatechnology.co.uk


News Articles [325 Associated News Articles listed on BioPortfolio]

AdFrontiers Announcing Beta Launch of Self-Serve Advertising Platform

NEW YORK, Feb. 7, 2018/PRNewswire/ --  AdFrontiersby J Carter Marketing, a leading provider of digital advertising technology, announced today the beta launch Read more...

Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Revision: 3, Authorised

Research suggests alternative treatment for beta blocker intolerant heart attack patients

(New York Institute of Technology) Beta blockers have become a prescription drug staple for recovering heart attack patients. However, these blood pressure-reducing medications cannot be tolerated by ...

Beta-amyloid dimers found in brains of patients with Alzheimer's

A new study proposes that the presence of two beta-amyloid molecules bound together (beta-amyloid dimers) could provide a new biomarker for AD.

Advice about beta-blockers

4 June 2018: Helen Williams, spokesperson on cardiovascular medicine at the Royal Pharmaceutical Society, spoke to the Daily Mail about beta-blockers. “Beta-blockers can cause a general slowing d...

Transgenic Mice Expressing CNO-sensitive Gq- or Gs-coupled Designer Receptors Selectively in Pancreatic Beta Cells

Impaired functioning of pancreatic beta cells is a key hallmark of type 2 diabetes. Beta cell function is modulated by the actions of different classes of heterotrimeric G proteins. The functional con...

Beta-blockers for HF According to Ejection Fraction

Which patients with heart failure benefit from treatment with beta-blockers? This study investigates the effect of beta-blockers on LVEF and prognosis, stratified according to the baseline LVEF. Eur...

Avivagen (VIV) - Antibiotic-free alternative for animal feed

Edison Investment Research - Pharmaceutical & healthcare - Avivagen: Avivagen is advancing feed additives based on its OxC-beta (fully oxidized beta-carotene) technology, which improves immune functio...

PubMed Articles [1106 Associated PubMed Articles listed on BioPortfolio]

Metformin, beta-cell development, and novel processes following beta-cell ablation in zebrafish.

Type 1 and 2 diabetes are characterized by a loss of insulin-producing beta-cells. Current treatments help maintain blood glucose levels but cannot provide a cure. As such, a vital target for the cure...

Matching-adjusted comparisons demonstrate better clinical outcomes with SC peginterferon beta-1a every two weeks than with SC interferon beta-1a three times per week.

Subcutaneous (SC) peginterferon beta-1a and SC interferon beta-1a (IFN beta-1a) have demonstrated efficacy in treating relapsing-remitting multiple sclerosis (RRMS) but have never been compared in dir...

Demonstration of Single-Barium-Ion Sensitivity for Neutrinoless Double-Beta Decay Using Single-Molecule Fluorescence Imaging.

A new method to tag the barium daughter in the double-beta decay of ^{136}Xe is reported. Using the technique of single molecule fluorescent imaging (SMFI), individual barium dication (Ba^{++}) resolu...

Hypertrophic effect of inhaled beta -agonist with and without concurrent exercise training: a randomized controlled trial.

Due to a high prevalence of asthma and exercise-induced bronchoconstriction in elite athletes, there is a high use of beta -adrenoceptor agonists (beta -agonists) in the athletic population. While ana...

The lifespan trajectory of neural oscillatory activity in the motor system.

Numerous studies connect beta oscillations in the motor cortices to volitional movement, and beta is known to be aberrant in multiple movement disorders. However, the dynamic interplay between these b...

Clinical Trials [2401 Associated Clinical Trials listed on BioPortfolio]

Investigating the Effects of Beta-Hydroxy-Beta-Methylbutyrate on Glucose Handling in Older and Younger Men.

We intend to examine the effect of a commercially available nutritional supplement, Beta-hydroxy-beta-methylbutyrate(HMB) on whole-body responses to a sugar load.

Thalassemia Treatment Based on the Stem Cell Technology

In order to study the transplantation effect of hematopoetic stem cells from beta-thalassemia induced pluripotent stem cells. We applied clinical grade source of autologous hematopoietic s...

Interaction Study SLV337/Simvastatin

To investigate the effect of multiple doses of SLV337 on the pharmacokinetics of simvastatin and simvastatin acid when co-administered in healthy male subjects

Phase I BP Interferon (IFN) Beta-004

Phase I study aiming at: - establishing the pharmacokinetic profile of interferon beta-1a after i.v. administration of the formulation BioPartners IFN beta-1a without albumin (HSA...

Is IFN-Beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta

This study is to find out if Interferon-beta (IFN-beta) can recover its effectiveness after a washout period in patients with Multiple Sclerosis who have previously developed neutralizing ...

Companies [521 Associated Companies listed on BioPortfolio]

Beta Technology Ltd

Beta Technology Ltd is a private company established in 1984, by Dr Bob Keown OBE. Originally a lecturer in Metallurgy at Sheffield University, Bob set up his own consultancy company in 1984 and later...

Beta Amyloid Org

Beta Amyloid.org keeps up details of Alzheimer Research Labs, Alzheimer Research conferences around the world. Amyloid peptides being one of the major culprit of the Alzheimer Disease so our goal is t...

BETA Healthcare Group

BETA Healthcare Group provides healthcare professional liability coverage to more than 150 hospitals and healthcare facilities in California. As the leading choice of liability in...

Beta-Cell

Beta-Cell is engaged in the development and commercialisation of innovative cell and drug therapies for the treatment of diabetes. The primary therapeutic focus of the company is on beta-cells, the hi...

Elan

Elan Corporation, plc is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and se...

More Information about "Beta Technology Ltd" on BioPortfolio

We have published hundreds of Beta Technology Ltd news stories on BioPortfolio along with dozens of Beta Technology Ltd Clinical Trials and PubMed Articles about Beta Technology Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Beta Technology Ltd Companies in our database. You can also find out about relevant Beta Technology Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record